Ashwagandha‐induced acute liver injury: A case report

Drug‐induced liver injury became one of the most important liver disorders and diagnostic challenge for clinicians and pathologists. Here, we report a rare case of ashwagandha‐induced acute liver injury. The patient developed jaundice 2 weeks after starting ashwagandha intake and recovered within 5 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Tóth, Marcell, Benedek, Andrea E., Longerich, Thomas, Seitz, Helmut‐Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014511/
https://www.ncbi.nlm.nih.gov/pubmed/36937644
http://dx.doi.org/10.1002/ccr3.7078
_version_ 1784907007343460352
author Tóth, Marcell
Benedek, Andrea E.
Longerich, Thomas
Seitz, Helmut‐Karl
author_facet Tóth, Marcell
Benedek, Andrea E.
Longerich, Thomas
Seitz, Helmut‐Karl
author_sort Tóth, Marcell
collection PubMed
description Drug‐induced liver injury became one of the most important liver disorders and diagnostic challenge for clinicians and pathologists. Here, we report a rare case of ashwagandha‐induced acute liver injury. The patient developed jaundice 2 weeks after starting ashwagandha intake and recovered within 5 months after withdrawal without any specific treatment.
format Online
Article
Text
id pubmed-10014511
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100145112023-03-16 Ashwagandha‐induced acute liver injury: A case report Tóth, Marcell Benedek, Andrea E. Longerich, Thomas Seitz, Helmut‐Karl Clin Case Rep Case Report Drug‐induced liver injury became one of the most important liver disorders and diagnostic challenge for clinicians and pathologists. Here, we report a rare case of ashwagandha‐induced acute liver injury. The patient developed jaundice 2 weeks after starting ashwagandha intake and recovered within 5 months after withdrawal without any specific treatment. John Wiley and Sons Inc. 2023-03-14 /pmc/articles/PMC10014511/ /pubmed/36937644 http://dx.doi.org/10.1002/ccr3.7078 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Tóth, Marcell
Benedek, Andrea E.
Longerich, Thomas
Seitz, Helmut‐Karl
Ashwagandha‐induced acute liver injury: A case report
title Ashwagandha‐induced acute liver injury: A case report
title_full Ashwagandha‐induced acute liver injury: A case report
title_fullStr Ashwagandha‐induced acute liver injury: A case report
title_full_unstemmed Ashwagandha‐induced acute liver injury: A case report
title_short Ashwagandha‐induced acute liver injury: A case report
title_sort ashwagandha‐induced acute liver injury: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014511/
https://www.ncbi.nlm.nih.gov/pubmed/36937644
http://dx.doi.org/10.1002/ccr3.7078
work_keys_str_mv AT tothmarcell ashwagandhainducedacuteliverinjuryacasereport
AT benedekandreae ashwagandhainducedacuteliverinjuryacasereport
AT longerichthomas ashwagandhainducedacuteliverinjuryacasereport
AT seitzhelmutkarl ashwagandhainducedacuteliverinjuryacasereport

Ejemplares similares